Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2023-2030
The Clinical Trial Equipment & Ancillary Solutions Market is projected to reach USD 7.62 billion by 2030 from USD 3.88 billion in 2022, at a CAGR of 8.78% during the forecast period.
Market Segmentation & Coverage:This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Clinical Trial Equipment & Ancillary Solutions Market.
- Based on Product, market is studied across Equipment, Services, and Systems. The Equipment is further studied across Imaging & Diagnostic Equipment and Laboratory Equipment. The Services is further studied across Ancillary Sourcing Services, Data Management & Analysis Services, Maintenance & Calibration Services, Regulatory & Compliance Services, Site Monitoring & Support Services, and Training & Consulting Services. The Ancillary Sourcing Services is further studied across Equipment Leasing & Rental Services, Procurement, and Supply & Logistics. The Systems is further studied across Clinical Trial Management Systems, Electronic Data Capture Systems, and Randomization & Trial Supply Management. The Equipment commanded largest market share of 48.80% in 2022, followed by Services.
- Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules. The Medical Devices commanded largest market share of 52.20% in 2022, followed by Biologic Drugs.
- Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV. The Phase I commanded largest market share of 32.09% in 2022, followed by Phase III.
- Based on End-Use, market is studied across Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Contract Research Organizations, and Medical Device Companies. The Biotechnology & Pharmaceutical Companies commanded largest market share of 36.54% in 2022, followed by Contract Research Organizations.
- Based on Indication, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Digestive Disorders, Immunology, Infectious Diseases, Metabolic Disorders, and Oncology. The Immunology commanded largest market share of 18.54% in 2022, followed by Oncology.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.35% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:The FPNV Positioning Matrix is an indispensable tool for assessing the Clinical Trial Equipment & Ancillary Solutions Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:The Market Share Analysis offers invaluable insights into the vendor landscape Clinical Trial Equipment & Ancillary Solutions Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systèmes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Koninklijke Philips N.V., Lonza Group Ltd., Mednet, Myonex, Inc., Navitas Life Sciences, Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited.
The report offers valuable insights on the following aspects:- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:- What is the market size and forecast for the Clinical Trial Equipment & Ancillary Solutions Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Clinical Trial Equipment & Ancillary Solutions Market?
- What is the competitive strategic window for identifying opportunities in the Clinical Trial Equipment & Ancillary Solutions Market?
- What are the latest technology trends and regulatory frameworks in the Clinical Trial Equipment & Ancillary Solutions Market?
- What is the market share of the leading vendors in the Clinical Trial Equipment & Ancillary Solutions Market?
- Which modes and strategic moves are suitable for entering the Clinical Trial Equipment & Ancillary Solutions Market?
Please Note: PDF & Excel + Online Access - 1 Year